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Voluntary shoulder abduction (SA) and finger extension (FE) 
measured within 72 hours after stroke have been shown to be 
important determinants for upper-limb capacity at 6 months 
poststroke.1-3 However, despite the high positive predictive 
value (PPV) of this SA and FE (SAFE) model when applied 
within 3 days poststroke,1 a relatively large number of 
patients without initially voluntary FE have been shown to be 
false negatives as a result of experiencing spontaneous return 
of FE in the first 3 months poststroke.4 Patient’s ability of 
voluntary FE is believed to reflect the intactness of the corti-
cospinal tract system (CTS) early poststroke.1-4
Several prospective cohort studies have shown that the 
integrity of the CST can be reliably and validly determined 
by transcranial magnetic stimulation (TMS)-induced motor-
evoked potentials (MEPs) of the adductor digiti minimi 
(ADM), the first dorsal interosseous, or abductor pollices 
brevis (APB) muscle.5 TMS-MEPs were obtained within 2 
days to 3 weeks poststroke onset.5 A few prognostic studies 
were retrospectively conducted, and most studies recruited 
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Abstract
Background. The added prognostic value of transcranial magnetic stimulation (TMS)-induced motor-evoked potentials (MEPs) 
to clinical modeling for the upper limb is still unknown early poststroke. Objective. To determine the added prognostic 
value of TMS of the adductor digiti minimi (TMS-ADM) to the clinical model based on voluntary shoulder abduction (SA) 
and finger extension (FE) during the first 48 hours and at 11 days after stroke. Methods. This was a prospective cohort 
study with 3 logistic regression models, developed to predict upper-limb function at 6 months poststroke. The first model 
showed the predictive value of SA and FE measured within 48 hours and at 11 days poststroke. The second model included 
TMS-ADM, whereas the third model combined clinical and TMS-ADM information. Differences between derived models 
were tested with receiver operating characteristic curve analyses. Results. A total of 51 patients with severe, first-ever 
ischemic stroke were included. Within 48 hours, no significant added value of TMS-ADM to clinical modeling was found 
(P = .369). Both models suffered from a relatively low negative predictive value within 48 hours poststroke. TMS-ADM 
combined with SA and FE (SAFE) showed significantly more accuracy than TMS-ADM alone at 11 days poststroke (P = 
.039). Conclusion. TMS-ADM showed no added value to clinical modeling when measured within first 48 hours poststroke, 
whereas optimal prediction is achieved by SAFE combined with TMS-ADM at 11 days poststroke. Our findings suggest 
that accuracy of predicting upper-limb motor function by TMS-ADM is mainly determined by the time of assessment early 
after stroke onset.
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small samples of stroke patients ranging from 6 to maxi-
mally 52 stroke patients.5 In addition, comparability 
between the prospective studies is hindered by differences 
in (1) criteria of recruiting stroke patients, (2) timing of 
measurements poststroke, (3) differences in initial motor 
impairment, and (4) differences in defining and timing of 
final outcome of upper-limb function. Furthermore, assess-
ing the added value of the accuracy of TMS-MEPs to clini-
cal modeling is hindered in most studies by not providing 
insight into the uncertainty that is associated with the accu-
racy of each prediction by failing to report 95% CIs for sen-
sitivity, specificity, and positive and negative predicted 
values. Finally, most studies found a predictive value of 
TMS-MEPs for outcome of upper paretic limb function, but 
none of these studies investigated the added value of TMS 
to clinical modeling alone when measured at the same day 
very early poststroke.
Based on the aforementioned methodological shortcom-
ings and differences in objectives, the surplus value of 
MEPs elicited with TMS in the acute stage is still unclear 
for outcome of upper-limb function in patients with a first-
ever ischemic hemispheric stroke.
The first aim of the present study was to determine the 
prognostic value of SAFE and TMS-MEPs of the ADM 
(TMS-ADM) in predicting upper-limb motor function at 6 
months in severe strokes when applied independently 
within the first 48 hours and at 11 days poststroke. The 
second aim was to determine if TMS-ADM improved the 
accuracy of predicting upper-limb function by the SAFE 




Patients with a first-ever, ischemic hemispheric stroke as 
revealed by MRI or CT scan were prospectively screened 
for eligibility and when possible recruited at a hospital 
department of neurology in the Netherlands from August 
11, 2004, until July 13, 2007. Stroke severity and etiology 
were classified following the TOAST (Trial of Org 10172 
in Acute Stroke Treatment) criteria6 within 24 hours by an 
experienced neurologist (PJSvdB) who was blinded for 
the TMS-ADM. To participate in this study, patients had 
to be hospitalized within the first day after the onset of 
symptoms with unilateral paralysis or significant paresis 
as defined by the National Institutes of Health Stroke 
Scale motor arm item: 0 < score < 5.7 Patients were 
excluded if (1) they had loss of consciousness; (2) they 
had peripheral nerve pathology, including diabetes and 
neuromuscular disease; (3) they were unable to receive 
rehabilitation because of severe comorbidity; and (4) con-
traindications to TMS were present, such as epileptic 
seizures, syncope, accompanying diagnosis of head 
trauma, hearing problems, cochlear implants, pregnancy, 
metal in the brain or skull, implanted devices such as car-
diac pacemaker and/or intracardiac lines, medication 
infusion device.8-10
All patients gave their written informed consent, and all 
patients were treated according to the Dutch physical ther-
apy guidelines of rehabilitation.11 This included early out-
of-bed mobilization within 24 hours poststroke, daily 
physical therapy interventions related to upper-limb train-
ing, and gait- and mobility-related functions and activi-
ties.11 The study protocol was approved by the local medical 
ethics committee.
Dependent Variable
The outcome in terms of upper-limb motor function was 
assessed at 6 months poststroke with the Fugl-Meyer upper-
extremity motor score (FM-UE). The FM-UE test was 
administered by an experienced rehabilitation physician 
(MHJH) who was not aware of the TMS-ADM results. The 
FM-UE test is a widely used measure to assess impairments 
of the upper limb after stroke and has been recommended as 
a robust measure to evaluate the ability to make arm move-
ments outside the synergistic pattern.12 The test covers 5 
hierarchical stages of motor recovery poststroke and con-
tains 33 test items for the upper paretic limb.13 The 33 items 
are divided into 4 subsections: shoulder-arm, wrist, hand, 
and upper-limb coordination. Each test item is scored on a 
3-point ordinal scale, with a maximal total score of 66 
points. The maximal score indicates maximal motor recov-
ery, equaling normal motor performance. The clinimetric 
properties such as intraobserver and interobserver reliabil-
ity; concurrent, predictive, content, and construct validity; 
and responsiveness of the FM-UE test are well estab-
lished.12,14,15 Recently, we showed after screening 460 
patients with a first-ever ischemic stroke at 6 months that 
FM-UE scores below 22 points correspond to “no” or “poor 
upper-limb capacity” based on the Action Research Arm 
Test (ARAT), whereas scores above 22 points represent 
limited to full upper-limb capacity based on the ARAT at 6 
months.16 Therefore, we dichotomized return of motor 
function into those who regained ≥22 points on the FM-UE 
(ie, favorable recovery) and those who stayed below 22 
points (ie, unfavorable recovery) at 6 months poststroke.
Independent Variables
Age, gender, left/right hemispheric stroke, dysphagia, dis-
orientation, and initial Barthel Index17 at stroke onset were 
selected as clinical descriptors for baseline characteristics 
of the population.18 The SAFE model was used for predict-
ing upper-limb function at 6 months instead of 26 weeks 
poststroke, measured within 48 hours (first assessment) and 
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at 11 days (second assessment) poststroke. In line with a 
previous prognostic study, FE was assessed with dichoto-
mized scores of the FM-UE test using a cutoff score of ≥1 
on this specific item. SA was assessed with the Motricity 
Index (MI), using a cutoff score of ≥9 on this specific item.1 
Nine points on the MI correspond with 1 point on the 
Medical Research Council Scale, reflecting visible contrac-
tion without segment movement.1
Stimulation Procedure
The TMS technique, including measurement of MEP-ADM 
with EMG recordings (Nihon Kohden Neuropack 8, Nihon 
Kohden, Tokyo, Japan), was performed according to the 
recommendations of the International Federation of Clinical 
Neurophysiology.10,19). The primary motor cortex (M1) was 
stimulated with a calibrated Magstim Dantec Maglite 
(Dantec Dynamics, Bristol, UK). Cortical TMS was applied 
through a figure-of-eight shaped coil. First, the hotspot that 
produced the highest MEP amplitude of the abductor digiti 
minimi (ADM) muscle was determined by moving the coil 
over the scalp in the hand area of M1 of the nonlesioned 
hemisphere, with the stimulator at submaximal output. 
Subsequently, the coil positioning at the optimal position 
(hotspot) was mirrored to the lesioned hemisphere to elicit 
a MEP. A positive MEP was defined as the presence of at 
least 3 responses out of 3 stimuli producing a MEP ampli-
tude of >50 µV.8,19 When no MEP could be elicited at a 
given position, the coil was slightly moved to find a hotspot 
in adjoining sites. Cervical stimulation was performed with 
a 90-mm circular coil to activate motor roots at the exit 
foramina centered over the C7/C8 cervical spine.19 Besides 
proximal muscles, the ADM is one of the preferred intrinsic 
muscles that can easily be examined as a target muscle for 
TMS analysis.19 Although all intrinsic hand muscles have 
nearly the same latency values, the ADM was chosen 
because of the relatively large data collection of normal val-
ues and bigger central representation in comparison to 
proximal target muscles.19 Alternatively, TMS measure-
ments can readily be recorded from the intrinsic hand mus-
cles. However, the anatomical arrangement of extrinsic, 
more proximal muscles in the forearm muscles, such as the 
extensor carpi radialis muscle, just make it more difficult to 
record from the target muscle in isolation, resulting in poly-
phasic waveforms.19 TMS-ADMs were evaluated by 2 
experienced, independent assessors. Both assessors were 
blinded with regard to the results of the clinical assess-
ments. In a previous study, we showed that the intraobserver 
and interobserver reliability of assessing TMS-ADM in 18 
stroke patients and 8 healthy age-matched controls was 
found to be good to excellent (0.45 < κ < 0.87).20 The TMS 
technique, including EMG recordings, was performed 
according to the recommendations of the International 
Federation of Clinical Neurophysiology.10
Data Analysis
Three prediction models were developed to predict upper-
limb motor function. The first model included clinical 
assessments alone, using voluntary SA and FE, measured 
within 48 hours and at 11 days poststroke. In the second 
model, the predictive value of TMS-ADM was investigated, 
whereas in the third model, the variables SA, FE, and TMS-
ADM were combined for both assessment times. With 
regard to the third model, regression analysis was used with 
the manually conducted stepwise backward selection 
method. This involved starting with all 3 variables, deleting 
the variable (if any) that improved the model the most by 
being deleted, and repeating this process until no further 
improvement was possible. Multivariate logistic regression 
was used to calculate the probability of upper-limb motor 
function at 6 months poststroke using the following equa-















2-way contingency table was used to calculate specificity, 
sensitivity, PPV, and negative predictive value (NPV) with 
corresponding 95% CIs. Receiver operating characteristic 
(ROC) curves of the different models at both time points 
poststroke were graphically displayed. Subsequently, dif-
ferences between AUCs were tested for significance. For 
each comparison, a z-statistic was calculated using the 













with r representing the Pearson product moment correlation 
coefficient between the 2 models.21 The calculated z-statis-
tic was defined significant if z ≥1.96. To maintain adequate 
power for the statistical analysis, we complied with the 
events per variable rule, which calls for at least 10 outcomes 
for each variable in the regression model.22 All tests were 
applied 2-tailed, with a critical value of α <.05 using SPSS 
software (SPSS version 21.0 SPSS Software: IBM 
Corporation, Armonk, New York, NY).
Results
Table 1 shows the main demographic and clinical character-
istics of the study sample. Figure 1 shows the flowchart of 
51 participants recruited with a first-ever, ischemic hemi-
spheric stroke. One participant was lost to follow-up after 
the first measurement because of migration outside the 
region. At 6 months poststroke, 32 (64%) participants 
showed FM-UE scores of 22 points or higher, of whom 6 
(12%) participants showed complete motor function (i.e., 
66 points on FM-UE). None of the participants reported dis-
comfort during the TMS assessments. TMS-ADM at 48 
hours and 11 days were present in 18 (36%) and 32 partici-
pants (64%), respectively.
Table 2 shows the SAFE model for the probability to 
achieve some upper-limb motor function 6 months after 
stroke. The probabilities when both SA and FE were present 
within 48 hours and at 11 days poststroke were .95 and .94, 
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respectively. The probability of achieving some dexterity 
when SA and FE were both absent was estimated to be .38 
within 48 hours and further decreased to .13 at 11 days post-
stroke. Table 2 shows also the 2-way contingency table 
analysis of this prediction model with SA and FE. Within 48 
hours, sensitivity of the SAFE model was 0.56 (95% CI = 
0.45-0.59), specificity 0.94 (95% CI = 0.75-1.00), PPV 0.95 
(95% CI = 0.76-1.00), and NPV 0.55 (95% CI = 0.44-0.58). 
At 11 days, sensitivity of the clinical model increased to 
0.75 (95% CI = 0.64-0.80), and specificity was 0.89 (95% 
CI = 0.69-0.98). The PPV was 0.92 (95% CI = 0.78-0.99), 
and NPV increased to 0.67 (95% CI = 0.52-0.74).
Table 3 presents the predictive value of TMS-ADM 
measured within 48 hours or at 11 days poststroke for pre-
dicting outcome of FM-UE at 6 months. Within 48 hours, 
the probability to achieve upper-limb function was .79 
when TMS-ADM was present and .35 when TMS-ADM 
was absent. At 11 days poststroke, the probability of achiev-
ing some dexterity when TMS-ADM was present increased 
to .88 and decreased to .22 when TMS-ADM was absent. 
Within 48 hours, sensitivity was 0.81 (95% CI = 0.70-0.90), 
specificity 0.61 (95% CI = 0.41-0.77), PPV 0.79 (95% CI = 
0.68-0.88), and NPV 0.65 (95% CI = 0.43-0.82). At 11 days 
poststroke, sensitivity was 0.88 (95% CI = 0.76-0.95) and 
specificity 0.78 (95% CI = 0.58-0.90). The PPV increased 
to 0.88 (95% CI = 0.76-0.95) and NPV increased to 0.78 
(95% CI = 0.58-0.90).
Table 4 shows the derived multivariable prediction 
model in which clinical determinants of SAFE and TMS-
ADM were combined for multivariable regression analyses. 
The probability of achieving some dexterity after 6 months 
poststroke was .96 when SAFE and TMS-ADM were pres-
ent and .27 when SAFE and TMS-ADM were absent within 
48 hours. At 11 days poststroke, the multivariable model of 
SAFE and TMS-ADM showed a probability of .95 when all 
determinants were present, whereas if all determinants were 
absent, the probability declined to .08. The 2-way contin-
gency table analyses showed a sensitivity of 0.72 (95% CI 
= 0.60-0.80), a specificity of 0.78 (95% CI = 0.57-0.92), a 
PPV of 0.85 (95% CI = 0.71-0.95) and NPV of 0.61 (95% 
CI = 0.44-0.72) within 48 hours. At 11 days poststroke, the 
sensitivity increased to 0.84 (95% CI = 0.73-0.89), specific-
ity increased to 0.89 (95% CI = 0.69-0.98), whereas the 
PPV increased to 0.93 (95% CI = 0.81-0.99) and NPV to 
0.76 (95% CI = 0.59-0.84), respectively.
Figure 2 shows the ROC analyses of the 3 different pre-
diction models within 48 hours poststroke. The AUC ranged 
from 0.793 for the SAFE model (SE = 0.064; P < .001; 95% 
CI = 0.667-0.919), 0.827 for the SAFE model with TMS-
ADM (SE = 0.057; P < .001; 95% CI = 0.716-0.939), and 
0.712 for the TMS-ADM model (SE = 0.080; P = .014; 95% 
CI = 0.555-0.869). Comparison of the 3 ROC curves 
showed that the AUC was not significantly different 
between the models (SAFE compared with SAFE and 
TMS-ADM: z = 0.8975, P = .366; SAFE compared with 
TMS-ADM: z = 0.8977, P = .3693; and SAFE and TMS-
ADM compared with TMS-ADM: z = 0.1.9087, P = .056).
Figure 3 shows the ROC analyses of the 3 prediction 
models measured at 11 days poststroke. The AUC ranged 
from 0.880 for the SAFE model (SE = 0.051; P < .001; 95% 
CI = 0.780-0.980), 0.905 for the SAFE model with TMS-
ADM (SE = 0.047; P < .001; 95% CI = 0.814-0.997), and 
0.826 for the TMS-ADM (SE = 0.067; P < .001; 95% CI = 
0.695-0.958). Comparison of the 3 ROC curves showed that 
the AUC was significantly different between the TMS-
ADM model and the SAFE plus TMS-ADM model in favor 
of the SAFE and TMS-ADM model combined (z = 2.060; P 
= .039). No significant difference was found between the 
SAFE model and the TMS-ADM model (z = 0.782; P = 
.434) and for the SAFE model and the SAFE model com-
bined with TMS-ADM (z = 0.821; P = .412).
Discussion
The present study aimed to demonstrate the added prognos-
tic value of TMS-ADM to the clinical SAFE model when 
Table 1. Demographic and Patient Characteristics Within 48 
Hours After Stroke Onset.
Patient Characteristics, n = 51 Total
Gender, F/M 30/21
Age, mean (range), years 70 (44-93)
Hemisphere of stroke, L/R 25/26
Time interval between stroke and  
 First assessment (hours), mean <48 hours
 Second assessment (days), mean (SD) 11 (2.56)
 Final assessment (days), mean (SD) 168 (9.50)
Length of hospital stay, median (range), days 13 (1-38)




Hemianopia or neglect, no/yes 39/12
Disorientation, no/yes 37/14
Level of consciousness, alert/not alert 38/13
MI arm (0-100), median (IQR) 18 (0-70)
FM-UE (0-66), median (IQR) 8 (3-50)
FM-UE finger extension, no/yes 32/19
MI shoulder abduction, no/yes 24/27
Aphasia, no/yes 8/43
Dysphagia, no/yes 34/17
BI total score (0-20), median (IQR) 5 (2-8)
BI urinary incontinence, no/yes 22/29
Abbreviations: BI, Barthel Index; F, female; FM-UE, Fugl-Meyer upper-
extremity motor score; IQR, interquartile range; L/R, left/right; LVD, 
large vessel disease; M, male; MI, Motricity Index; SVD, small vessel 
disease; TOAST, Trial of Org 10172 in Acute Stroke Treatment 
classification.
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Figure 1. Flowchart for recruitment of first-ever, cortical ischemic hemispheric stroke patients within 48 hours and follow-up 
combined with dropout at 11 days, and 3 and 6 months poststroke.
Table 2. Prognostic Values and Probabilities of Achieving Upper-Limb Motor Function (FM-UE ≥ 22 Points) 6 Months After Stroke, 


















P = 1/{1 + 1 × [exp(−0.486 + 0.891 × SA + 2.485 × FE)]}
SA FE  
+ + 17 14 1 18 .95 56 94 95 55
+ − .60  
− + .88  
− − .38  
Day 11
P = 1/{1 + 1 × [exp(−1.860 + 1.987 × SA + 2.667 × FE)]}
SA FE  
+ + 16 8 2 24 .94 75 89 92 67
+ − .53  
− + .69  
− − .13  
Abbreviations: FE, finger extension; FM-UE indicate Fugl-Meyer upper limb motor score; NPV, negative predictive value; PPV, positive predictive value; 
SA, shoulder abduction.
Hoonhorst et al 687
applied within the first 48 hours or at 11 days poststroke in 
an attempt to improve the accuracy of predicting upper-
limb function for achieving 22 points or more on FM-UE at 
6 months after severe stroke. The present study shows in a 
prospective cohort of stroke patients with severe motor 
impairment that the accuracy of predicting a favorable or 
unfavorable outcome was not significantly better for TMS-
ADM when compared with clinical modeling based on the 
SAFE model1 if applied at the same day poststroke. A 
slightly, even lower accuracy was observed for the TMS-
ADM (P = .039), when compared with TMS-ADM com-
bined with the clinical SAFE model at 11 days. The present 
Table 3. Prognostic Values and Probabilities of Achieving Upper-Limb Motor Function (FM-UE ≥ 22 Points) 6 Months After Stroke, 


















P = 1/{1 + 1 × [exp(−0.606 + 1.918 × TMS-ADM)]}
TMS-ADM
+ 11 6 7 26 .79 81 61 79 65
− .35  
Day 11
P = 1/{1 + 1 × [exp(−1.253 + 3.199 × TMS-ADM)]}
TMS-ADM
+ 14 4 4 28 .88 88 78 88 78
− .22  
Abbreviations: FM-UE, Fugl-Meyer upper-limb motor score; NPV, negative predictive value; PPV, positive predictive value; TMS-ADM, transcranial 
magnetic stimulation of the adductor digiti minimi muscle.
Table 4. Prognostic Values and Probabilities of Achieving Upper-Limb Motor Function (FM-UE ≥ 22 points) 6 Months After Stroke, 


















P = 1/{1 + 1 × [exp(−0.984 + 0.426 × SA +2438 × FE + 1217 × TMS-ADM)]}
SA FE TMS-ADM  
+ + + 14 9 4 23 .96 72 78 85 61
+ + − .87  
+ − + .66  
+ − − .36  
− + + .94  
− + − .81  
− − + .56  
− − − .27  
Day 11
P = 1/{1 + 1 × [exp(−2392 + 1836 × SA + 1680 × FE + 11913 × TMS-ADM)]}
SA FE TMS-ADM  
+ + + 16 5 2 27 .95 84 89 93 76
+ + − .75  
+ − + .80  
+ − − .36  
− + + .77  
− + − .33  
− − + .38  
− − − .08  
Abbreviations: FE, finger extension; FM-UE, Fugl-Meyer upper-limb motor score; NPV, negative predictive value; PPV, positive predictive value; SA, 
shoulder abduction; TMS-ADM, transcranial magnetic stimulation of the adductor digiti minimi muscle.
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study further emphasizes that the diagnostic accuracy of 
TMS-ADM is, like return of voluntary FE,23 time depen-
dent24,25 and mainly driven by poorly understood processes 
of spontaneous neurobiological recovery.25 Finally, the cur-
rent study shows that the added value of diagnostic TMS for 
predicting FM-UE should always be seen in light of the cur-
rent set of powerful clinical tests available for making a 
valid prognosis early poststroke.1,24,25
Assuming that TMS-ADM may reflect the intactness of 
CST, the relatively low NPV and low specificity suggest that 
an initial absence of TMS-ADM may be masked by pro-
cesses such as corticospinal diaschisis that suppresses the 
conductivity of CST very early poststroke.26-28 The time 
dependence of accurate prediction of outcome early post-
stroke1,23,25 may further clarify the seemingly conflicting 
results of the added value of TMS-ADM to clinical model-
ing, next to observed differences in patient selection, type of 
TMS equipment, and defining outcome.5,28 Future studies are 
needed to distinguish those patients who are likely to be false 
negatives and following the expected amount of spontaneous 
neurological recovery poststroke from patients who are true 
negatives and failed to show spontaneous neurobiological 
recovery. Recently, a number of prospective studies showed 
that about 20% to 30% of first-ever ischemic strokes do not 
follow the expected 70% rule of spontaneous neurobiological 
recovery early poststroke.29-31 Probably, this proportional 
recovery rule is dependent on the intactness of the ipsile-
sional CTS as revealed by TMS-MEP and fractional anisot-
ropy of the posterior limbs of the internal capsule.29 
Unfortunately, the biomarkers for identifying these (almost 
none) spontaneously recovering stroke patients are lacking in 
the literature and a main target for further translational 
research29,32-34 to improve the underpowered designs of 
stroke recovery trials in the near future.33,35
This study has some limitations. First, the sample size 
was limited, and our model may not be applicable to patients 
with brainstem, hemorrhagic, or recurrent strokes. Second, 
although the reliability of TMS-induced MEPs of the ADM 
in the affected hemisphere after ischemic stroke was found 
to be moderate to excellent,20,28 the selection of ADM 
instead of other distal intrinsic muscles such as APB consti-
tutes an arbitrary choice. Therefore, future studies should 
investigate if MEPs of finger extensors, which may reflect 
more the intactness of corticospinal control, such as the 
Figure 2. Receiver operating characteristic (ROC) curve 
plots for the 3 prediction models to predict upper-limb motor 
function within 48 hours poststroke. In the first model (blue 
line), the predictive value of transcranial magnetic stimulation–
induced motor-evoked potentials of the adductor digiti minimi 
muscle (TMS-ADM) was investigated. The second model 
(green line) included clinical assessments alone, using voluntary 
shoulder abduction (SA) and finger extension (FE), whereas in 
the third model (red line) the variables SA, FE, and TMS-ADM 
were combined.
Figure 3. Receiver operating characteristic (ROC) curve 
plots for the 3 prediction models to predict upper-limb motor 
function at 11 days poststroke. In the first model (blue line), the 
predictive value of transcranial magnetic stimulation–induced 
motor-evoked potentials of the adductor digiti minimi muscle 
(TMS-ADM) was investigated. The second model (green line) 
included clinical assessments alone, using voluntary shoulder 
abduction (SA) and finger extension (FE), whereas in the third 
model (red line) the variables SA, FE, and TMS-ADM were 
combined.
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extensor indices muscle,36 may further improve the prog-
nostic accuracy of TMS very early poststroke. Third, the 
second assessment in this prospective cohort was set at 11 
days poststroke, which was a pragmatic choice, related with 
length of hospitalization.
Future studies are needed to reveal the added value of 
other innovative methods such as structural29,34 and func-
tional neuroimaging techniques early poststroke.37 For 
example, diffusion tensor imaging (DTI) indexing the 
extent of white matter damage may have an added value to 
clinical modeling and TMS-ADM.38 However, the accuracy 
of DTI as defined by the initial fiber number ratio at 24 and 
72 hours poststroke as a surrogate marker of corticospinal 
tract integrity may be hindered by the fact that Wallerian 
degeneration also requires time to manifest itself in the first 
days poststroke.34,39 Finally, the review of 71 prognostic 
studies investigating the internal validity of neurological 
biomarkers, such as DTI, TMS, fMRI, and structural MRI 
as a predictor alone or in combination with clinical bio-
markers of stroke recovery, revealed that 50 (2/3) studies 
suffered from insufficient robustness and poor methodolog-
ical quality.32 In particular, small sample sizes, the accom-
panying uncertainty about the minimal clinically important 
difference, and lack of cross-validation made the authors 
conclude that neurological biomarkers in combination with 
behavioral clinical measures are more accurate than models 
that used neurological biomarkers alone.32
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